Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Gross PP&E Adjustments (2018 - 2026)

Arcturus Therapeutics Holdings filings provide 8 years of Other Gross PP&E Adjustments readings, the most recent being -$1.9 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 65.23% to -$1.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.9 million, a 65.23% increase, with the full-year FY2025 number at -$1.9 million, up 65.23% from a year prior.
  • Other Gross PP&E Adjustments hit -$1.9 million in Q4 2025 for Arcturus Therapeutics Holdings, up from -$4.4 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $6.8 million in Q1 2022 to a low of -$20.7 million in Q2 2022.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$5.8 million (2024), compared with a mean of -$5.9 million.
  • The widest YoY moves for Other Gross PP&E Adjustments: up 6222.43% in 2022, down 2965.01% in 2022.
  • Arcturus Therapeutics Holdings' Other Gross PP&E Adjustments stood at $4.3 million in 2021, then tumbled by 435.13% to -$14.3 million in 2022, then skyrocketed by 48.89% to -$7.3 million in 2023, then rose by 27.29% to -$5.3 million in 2024, then surged by 65.23% to -$1.9 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were -$1.9 million (Q4 2025), -$4.4 million (Q3 2025), and -$3.3 million (Q2 2025) per Business Quant data.